The MASH-TAG Conference unites leaders in clinical, academic, and pharmaceutical fields to improve outcomes for patients with MASH. IMA Clinical Research is a recognized leader in MASH studies, building a large patient database through community partnerships. With advanced imaging capabilities and high enrollment rates, especially in diverse communities, we are at the forefront of MASH research. Connect with our team—Kevin Short, Director, Business Development, and Yu-Mei Liu, MD, Principal Investigator—to discuss how our site network can bring new MASH treatments to patients.